
Activist Takes $1B Stake in Pfizer, 'The Joker' Sequel Flops at the Box Office
The Rundown
00:00
Box Office Flop and Stock Market Insights
This chapter examines the underwhelming performance of the new Joker sequel, which fell short of expectations at the box office, and explores the financial implications for Warner Brothers. It also highlights Alibaba's impressive stock rise following positive market predictions related to China's economy.
Transcript
Play full episode